Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03075553
Title Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST